Sequence LifeScience, Inc. – Trademark Portfolio

Entity Type: 03

Sequence LifeScience, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 7 are pending. Notable registered marks include EMERGE, SENTRY, and SHELTER. The owner is based in San Antonio, TX.

4590 Lockhill Selma Road

San Antonio, TX 78249

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Sequence LifeScience, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Sequence LifeScience, Inc. have?

Sequence LifeScience, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 7 pending, 1 abandoned.

What trademark classes does Sequence LifeScience, Inc. file in?

Sequence LifeScience, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Sequence LifeScience, Inc.'s most well-known trademarks?

Sequence LifeScience, Inc.'s registered trademark portfolio includes well-known marks such as EMERGE, SENTRY, and SHELTER. These are among 3 currently registered trademarks in the portfolio.

What is Sequence LifeScience, Inc.'s trademark registration success rate?

Sequence LifeScience, Inc. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 7 applications are pending review.